Elevance Health reported $201.1B of revenue over the trailing twelve months, +6.3% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $201.1B (to Q2 2026). Net income: $4.96B, trailing twelve months to Q2 2026. Free cash flow: $6.29B, trailing twelve months to Q2 2026. Operating margin: 2.7%, trailing twelve months to Q2 2026.

ELVElevance Health

Healthcare

$412.79+33% 1Y

$412.79

$277.8952 weeks$430.21

ELV as reported

Elevance Health reported $201.1B of revenue over the trailing twelve months, +6.3% on the year before. 11 reported series are charted on this page, each one as filed.

$201.1B

Revenue, trailing twelve months · to Q2 2026 · +6.3% against the twelve months before

Net income: $4.96B
Net income · −7.4% year on year · trailing twelve months to Q2 2026
Free cash flow: $6.29B
Free cash flow · +18% year on year · trailing twelve months to Q2 2026
Operating margin: 2.7%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ELV, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$201.1B	+6.3%	Q2 2026
Net income	$4.96B	−7.4%	Q2 2026
EPS	$22.57	−4.2%	Q2 2026
Gross margin	89%	n/a	Q2 2026
Operating margin	2.7%	n/a	Q2 2026
Net margin	2.5%	n/a	Q2 2026
ROE	12%	n/a	Q2 2026
ROA	4.3%	n/a	Q2 2026
ROIC	13%	n/a	Q2 2026
Free cash flow	$6.29B	+18%	Q2 2026
P/E	18.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.